Aug 20, 2020 / 11:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Mayne Pharma Group Limited Results Full Year Call. At this time, I'd like to turn the conference over to Mr. Scott Richards. Please go ahead, sir.
Scott Anthony Richards - Mayne Pharma Group Limited - MD, CEO & Executive Director
Thank you and good morning, everybody. Thank you for joining us today to discuss Mayne Pharma's Full Year 2020 Financial Results. I'm joined on the call by Peter Paltoglou, our Interim CFO and Chief Development Officer. What I'd like to do this morning is give you a brief update on the business and how our operating segments have performed and together with an update on our pipeline and strategic growth plans. Pete will then provide some additional details on our financial results. And then we will open up the call to questions.
First of all, despite the challenges of COVID-19, our 2 key sites in Greenville and Salisbury have been fully operational, and our external supply partners have serviced us well. As a pharmaceutical business, we have a critical role during the
Full Year 2020 Mayne Pharma Group Ltd Earnings Call Transcript
Aug 21, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers